Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in various forms, such as pills, tablets, capsules and injections. Botanical drugs, such as aescin, adoniside, atropine and berberine, are derived from plants. These drugs are used as an important component of traditional medicine and therapies, such as homeopathy and ayurvedic medicines. Some of the major classes of plant drugs are terpenes, steroids, glycosides and phenols.
Globally, increased usage of botanical drugs as an alternative to synthetic medicine and increasing prevalence of various chronic diseases are some of the major drivers for growth of botanical and plant derived drugs. In addition, low cost of botanical drugs and technological advancement in production procedure of botanical drugs are also supporting in growth of botanical and plant derived drugs market. However, stringent laws and regulations for approval of botanical drugs is a key restraint for botanical and plant derived drugs market.
Moreover, increasing number of mergers and acquisitions by manufacturing companies is a key trend for botanical and plant derived drugs market.
The global Botanical and Plant Derived Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Botanical and Plant Derived Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Botanical and Plant Derived Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Botanical and Plant Derived Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Botanical and Plant Derived Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abott Laboratories
Bayer Healthcare
Bionova
Bristol Myers
Curapharm
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Tablets
Capsules
Pills
Injections
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Summary:
Get latest Market Research Reports on Botanical and Plant Derived Drugs. Industry analysis & Market Report on Botanical and Plant Derived Drugs is a syndicated market report, published as Global Botanical and Plant Derived Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Botanical and Plant Derived Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.